Controlled-Release Delivery of Ovarian Anticancer Paclitaxel via Vortex Ring, Donut-Shaped Hydrogels
ISEF · 2018 Translational Medical Science
Overview
Ovarian cancer affects countless women worldwide. Unfortunately, systemic chemotherapy for treatment of ovarian cancer necessitates one-time super dosing, leading to the onset of severe side effects, and like radiation therapy, causes the destruction of neighboring, healthy cells. A method where chemotherapy is temporarily implanted at the cancer and subsequently time-released would be preferred, to adhere the drug to the tumor, and minimize side effects associated with immediate overdosing. Here, such a device is engineered, via donut-shaped hydrogel vortex rings that are formed and loaded with a chemotherapy agent. Specifically, 750µg of paclitaxel (PAC) is dissolved in 1ml aqueous 2% sodium alginate, a droplet of which is then injected into a 5mM CaCl2 and 95mM MgCl2 buffer to create a 1mm vortex ring hydrogel, with a 7.5µg drug load. Under simulated ovarian conditions, each sticky, PAC-loaded vortex ring steadily releases its chemotherapy, so that 50% is released in 4hours, with up to 5.4µg delivered in a maximum of 20hours (72% release), post-application. Simulation of pointed placement of the PL-VRH donuts, their adherence to a cancerous tumor in the ovarian cavity, resistance to movement due to aqueous conditions, and subsequent release of the paclitaxel, was carried out using a porcine intestine membrane model. For delivery of a localized PAC dosage that concurs current IP-injection (342µg for a typical 57cm2 ovary), it was determined that ~60 hydrogel vortex rings can be directly delivered to the ovarian site via 600µl injection of medicated precursor, ensuring direct and extended interaction of the chemotherapy and cancer.
Competition history
- ISEF 2018
Resources
Related projects
ISEF · 2020
Hierarchically Engineered Nanotheranostic for Ovarian Cancer
JSHS · 2020
Hierarchically Engineered Nanotheranostic for Ovarian Cancer
ISEF · 2026
Nano-Enabled Encapsulation for Doxorubicin
ISEF · 2014
A Novel In-Clinic Patient- and Cancer- Tailored Targeted Drug Delivery System
ISEF · 2020
Dual-Stimuli Responsive Nanomedicine for Cancer Therapy
ISEF · 2015
Developing a Stimuli Responsive Drug Delivery System Based on the Non-covelant Self Assembly of Phospholipid/Polymers on Single Walled Carbon Nanotubes
ISEF · 2015
Synthesis of an Electromagnetically-Controlled Corn-Starch/PVA Biopolymer Microcube for Extended and Targeted Drug Delivery
ISEF · 2024
Developing a Polyethylene Glycol Hydrogel Based Controlled Delivery System Using the Alkyl Radical Initiator AIPH as an Antitumor Therapy
Closest projects by meaning, across every fair and year in the corpus.
Browse more like this
Source: Regeneron International Science and Engineering Fair